Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis

NCT00279760 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Belatacept
DRUG: Abatacept

Sponsor

Bristol-Myers Squibb